GUGLIELMI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 76
AS - Asia 42
EU - Europa 26
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 3
Totale 155
Nazione #
US - Stati Uniti d'America 70
SG - Singapore 21
IT - Italia 14
BD - Bangladesh 9
CN - Cina 5
RU - Federazione Russa 4
VN - Vietnam 4
BR - Brasile 3
GB - Regno Unito 3
CA - Canada 2
CR - Costa Rica 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IN - India 1
JM - Giamaica 1
KR - Corea 1
LT - Lituania 1
NI - Nicaragua 1
PK - Pakistan 1
PL - Polonia 1
SE - Svezia 1
TT - Trinidad e Tobago 1
Totale 147
Città #
Singapore 16
Dallas 9
San Jose 9
Ashburn 4
Carrboro 3
Los Angeles 3
Chicago 2
Columbus 2
Council Bluffs 2
Fresno 2
Hanoi 2
Memphis 2
New York 2
Rome 2
Agnadello 1
Baltimore 1
Beijing 1
Binasco 1
Brentwood 1
Brooklyn 1
Calcinelli 1
Camden 1
Chaguanas 1
Charleston 1
Chennai 1
Cherry Hill 1
Cumming 1
Denver 1
Dublin 1
Estes Park 1
Fort Worth 1
Hammond 1
Hefei 1
Heredia 1
Ho Chi Minh City 1
Houston 1
Indianapolis 1
Khanewal 1
Kingston 1
Kyle 1
London 1
Lucca 1
Managua 1
Milan 1
Naples 1
Norwood 1
Olomouc 1
Orem 1
Orizona 1
Ottawa 1
Phoenix 1
Redondo Beach 1
Saint Paul 1
Santa Clara 1
Seoul 1
Shanghai 1
Sombrio 1
Spinea 1
Stockholm 1
Tongling 1
Toronto 1
Vila Velha 1
Vilnius 1
Warsaw 1
Washington 1
Totale 111
Nome #
A Multitarget Approach against Neuroinflammation: Alkyl Substituted Coumarins as Inhibitors of Enzymes Involved in Neurodegeneration 115
Potential of MAO-B Inhibitors with Multi-target Inhibition and Antioxidant Properties for the Treatment of Neurodegenerative Disorders 26
Liposomes versus Sphingosomes: Microfluidic DoE-Guided development of lipid nanocarriers for the delivery of a synthetic hMAO inhibitor 14
Totale 155
Categoria #
all - tutte 602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20246 0 0 0 0 0 0 2 2 0 0 0 2
2024/202521 1 4 3 1 2 0 1 0 3 1 1 4
2025/202682 5 4 11 9 3 2 11 5 5 8 6 13
2026/202746 1 9 9 17 10 0 0 0 0 0 0 0
Totale 155